DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 1 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $707,000 | -54.9% | 35,076 | -16.4% | 0.00% | – |
| Q2 2021 | $1,566,000 | +50.1% | 41,940 | +2.9% | 0.00% | – |
| Q1 2021 | $1,043,000 | +34666.7% | 40,772 | +35353.9% | 0.00% | – |
| Q4 2020 | $3,000 | -84.2% | 115 | -88.9% | 0.00% | – |
| Q3 2020 | $19,000 | -38.7% | 1,034 | -16.2% | 0.00% | – |
| Q2 2020 | $31,000 | +416.7% | 1,234 | +342.3% | 0.00% | – |
| Q1 2020 | $6,000 | -89.7% | 279 | -89.4% | 0.00% | – |
| Q4 2019 | $58,000 | +222.2% | 2,635 | +121.1% | 0.00% | – |
| Q3 2018 | $18,000 | +800.0% | 1,192 | +679.1% | 0.00% | – |
| Q2 2018 | $2,000 | -77.8% | 153 | -84.9% | 0.00% | – |
| Q4 2017 | $9,000 | – | 1,016 | +11188.9% | 0.00% | – |
| Q3 2017 | $0 | – | 9 | -59.1% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 22 | -97.0% | 0.00% | – |
| Q3 2015 | $6,000 | -57.1% | 722 | -25.6% | 0.00% | – |
| Q2 2015 | $14,000 | – | 970 | +48400.0% | 0.00% | – |
| Q4 2014 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |